241 related articles for article (PubMed ID: 23082931)
1. Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates.
Marinšek ZP; Nolde N; Kardum-Skelin I; Nizzoli R; Onal B; Rezanko T; Tani E; Ostović KT; Vielh P; Schmitt F; Kocjan G
Cytopathology; 2013 Feb; 24(1):7-20. PubMed ID: 23082931
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.
Domanski AM; Monsef N; Domanski HA; Grabau D; Fernö M
Cytopathology; 2013 Feb; 24(1):21-5. PubMed ID: 22783929
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
[TBL] [Abstract][Full Text] [Related]
4. Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma.
Bueno Angela SP; Viero RM; Soares CT
Cytopathology; 2013 Feb; 24(1):26-32. PubMed ID: 22220518
[TBL] [Abstract][Full Text] [Related]
5. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides.
Tabbara SO; Sidawy MK; Frost AR; Brosky KR; Coles V; Hecht S; Radcliffe G; Sherman ME
Cancer; 1998 Dec; 84(6):355-60. PubMed ID: 9915137
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries.
Rhodes A; Jasani B; Balaton AJ; Miller KD
J Clin Pathol; 2000 Apr; 53(4):292-301. PubMed ID: 10823126
[TBL] [Abstract][Full Text] [Related]
7. ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies.
Ferguson J; Chamberlain P; Cramer HM; Wu HH
Diagn Cytopathol; 2013 Jul; 41(7):575-81. PubMed ID: 22807465
[TBL] [Abstract][Full Text] [Related]
8. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
9. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F
Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry.
Radhika K; Prayaga AK
Indian J Cancer; 2010; 47(2):148-50. PubMed ID: 20448377
[TBL] [Abstract][Full Text] [Related]
12. Estrogen, progesterone, and HER-2 receptor immunostaining in cytology: the effect of varied fixation on human breast cancer cells.
Maleki S; Dorokhova O; Sunkara J; Schlesinger K; Suhrland M; Oktay MH
Diagn Cytopathol; 2013 Oct; 41(10):864-70. PubMed ID: 23447357
[TBL] [Abstract][Full Text] [Related]
13. Optimization and validation of immunocytochemical detection of oestrogen receptors on cytospins prepared from fine needle aspiration (FNA) samples of breast cancer.
Srebotnik Kirbiš I; Us Krašovec M; Pogačnik A; Strojan Fležar M
Cytopathology; 2015 Apr; 26(2):88-98. PubMed ID: 24807705
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical determination of hormonal receptors on cell-blocks from fine-needle cytopunctures of breast carcinoma].
Briffod M; Le Doussal V; Spyratos F
Bull Cancer; 2001 Oct; 88(10):1028-35. PubMed ID: 11713039
[TBL] [Abstract][Full Text] [Related]
15. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
[TBL] [Abstract][Full Text] [Related]
16. Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.
Kumar SK; Gupta N; Rajwanshi A; Joshi K; Singh G
Cytopathology; 2012 Jun; 23(3):181-6. PubMed ID: 21375607
[TBL] [Abstract][Full Text] [Related]
17. Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma.
Gong Y; Symmans WF; Krishnamurthy S; Patel S; Sneige N
Cancer; 2004 Feb; 102(1):34-40. PubMed ID: 14968416
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?
Muchiri LW
East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903
[TBL] [Abstract][Full Text] [Related]
19. Cytologic evaluation of prognostic markers in breast carcinoma.
Jayaram G; Elsayed EM
Acta Cytol; 2005; 49(6):605-10. PubMed ID: 16450899
[TBL] [Abstract][Full Text] [Related]
20. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M
Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
